Baxter International Inc.
Price Chart
Financials
※ FY = Fiscal Year
Investment Metrics(as of 2026-06-18)
| Metric | Value |
|---|---|
| Size | |
| Market Cap | $10.28B |
| Revenue | $11.32B |
| Net Income | $-1.10B |
| Total Assets | $19.85B |
| Net Assets | $6.04B |
| Employees | 37,500 |
| Value | |
| P/B | 1.70x |
| P/S | 0.91x |
| EV/EBITDA | 24.13x |
| FCF Yield | 6.95% |
| Profitability | |
| ROE | -18.17% |
| ROA | -5.53% |
| Op. Margin | -2.65% |
| Revenue Growth | 2.90% |
| Earnings Growth | -111.90% |
| Financial Health | |
| Debt Ratio | 228.86% |
| Total Debt | $9.69B |
| FCF | $714M |
| Cash | $2.02B |
| Current Ratio | 1.85x |
| Net Debt/EBITDA | 10.31x |
| Dividend | |
| Div. Yield | 2.59% |
| Div. Growth | -41.36% |
| Performance | |
| 1Y Return | -32.67% |
| 1M Return | 8.59% |
| From 52W High | -36.82% |
| 1Y MDD | -52.92% |
| Trading | |
| Volume | 5,555,400 shares |
| Trading Value | $110M |
| Per Share | |
| EPS | $-1.86 |
| BPS | $11.92 |
Company Info
Baxter International Inc., through its subsidiaries, provides a portfolio of healthcare products in the United States. The company operates through three segments: Medical Products & Therapies, Healthcare Systems & Technologies, and Pharmaceuticals. It offers sterile intravenous (IV) solutions; infusion systems and devices; parenteral nutrition therapies; inhaled anesthetics; generic injectable pharmaceuticals; surgical hemostat and sealant products; advanced surgical equipment; smart bed systems; patient monitoring and diagnostic technologies; and respiratory health devices, as well as advanced equipment for the surgical space comprising operating room integration technologies, precision positioning devices, and other accessories. The company also provides specialty injectable pharmaceuticals, inhaled anesthetics, and drug compounding services. Its products are used in hospitals, nursing homes, rehabilitation centers, ambulatory surgery centers, doctors' offices, kidney dialysis centers, and patients at home under physician supervision. The company sells its products through direct sales force, independent distributors, drug wholesalers, and specialty pharmacy or other alternate site providers. It operates in Eastern Europe, the Middle East, Africa, Latin America, Asia, Western Europe, Canada, Japan, Australia, and New Zealand. Baxter International Inc. was incorporated in 1931 and is headquartered in Deerfield, Illinois.